These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 14944438)

  • 1. [Effect of heparin on prothrombinic activity, on circulatory anticoagulants (antithromboplastin, plasma and serum antithrombin, antifibrinogen, on utilization of prothrombin, on conversion and acceleration factors in prothrombin conversion, on proteinemia, and on protein fraction].
    MARRAZZA P; DI GIROLAMO L
    Arch Sci Med (Torino); 1952 Jan; 93(1):9-16. PubMed ID: 14944438
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of a new laboratory test to evaluate antithrombin resistance in plasma.
    Murata M; Takagi A; Suzuki A; Okuyama E; Takagi Y; Ando Y; Kato I; Nakamura Y; Murate T; Matsushita T; Saito H; Kojima T
    Thromb Res; 2014 Feb; 133(2):293-8. PubMed ID: 24325876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A HEPARIN-TYPE ANTITHROMBIN IN A GAMMA-MYELOMA. CONSIDERATIONS ON SPONTANEOUS ANTICOAGULANTS IN KAHLER'S DISEASE].
    FAVRE-GILLY J; CREYSSEL R; THOUVEREZ JP; REVOL L; CROIZAT P
    Hemostase; 1963; 3():325-33. PubMed ID: 14151020
    [No Abstract]   [Full Text] [Related]  

  • 4. Antithrombin III: a backward glance o'er travel'd roads.
    Seegers WH
    Adv Exp Med Biol; 1975; 52():195-215. PubMed ID: 47704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the antithrombin and heparin cofactor activities of a fraction adsorbed from plasma by aluminum hydroxide.
    MONKHOUSE FC; FRANCE ES; SEEGERS WH
    Circ Res; 1955 Jul; 3(4):397-402. PubMed ID: 14390722
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies upon the relation between plasma antithrombin and heparin; influence of plasma antithrombin on prothrombin time.
    TANTURI CA; WETZEL NC
    Am J Med Sci; 1949 Apr; 217(4):410-20. PubMed ID: 18115156
    [No Abstract]   [Full Text] [Related]  

  • 7. INACTIVATION OF PURIFIED AUTOPROTHROMBIN I WITH ANTITHROMBIN.
    SEEGERS WH; SCHROEER H; KAGAMI M
    Can J Biochem; 1964 Oct; 42():1425-35. PubMed ID: 14240727
    [No Abstract]   [Full Text] [Related]  

  • 8. CRYOCOAGULOPATHY WITH PRESENCE OF IMMUNOANTITHROMBIN IN THE COURSE OF LUPUS ERYTHEMATOSUS DISSEMINATUS.
    STRUZIK T; HANICKI Z; HAWIGER J; BIERNACKA B
    Acta Med Pol; 1964; 5():61-80. PubMed ID: 14133809
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduced inhibition of activated prothrombin by heparin and venous thromboembolism: heparin resistance revisited.
    Legnani C; Preda L; Palareti G; Lunghi B; Rossi E; Coccheri S
    Haematologica; 2002 Feb; 87(2):182-8. PubMed ID: 11836169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
    Meddahi S; Bara L; Fessi H; Samama MM
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The antithrombin effect of heparin; role of heparin concentration].
    BURSTEIN M
    C R Seances Soc Biol Fil; 1952 May; 146(9-10):641-2. PubMed ID: 12998196
    [No Abstract]   [Full Text] [Related]  

  • 12. STUDIES ON THROMBIN INACTIVATION IN NORMAL PLASMA, SERUM AND PLASMA FRACTIONS, AND ITS RELATION TO HEPARIN.
    BLOMBAECK B; BLOMBAECK M; OLSSON P
    Thromb Diath Haemorrh; 1963 Jul; 143():368-86. PubMed ID: 14081260
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thrombin time and antithrombin power of human plasma in the presence of heparin and some synthetic heparinoids].
    BURSTEIN M; GUINAND A
    J Physiol (Paris); 1955; 47(1):115-7. PubMed ID: 13243272
    [No Abstract]   [Full Text] [Related]  

  • 14. Routine coagulation assays underestimate levels of antithrombin-dependent drugs but not of direct anticoagulant drugs in plasma from patients with cirrhosis.
    Potze W; Arshad F; Adelmeijer J; Blokzijl H; van den Berg AP; Porte RJ; Lisman T
    Br J Haematol; 2013 Dec; 163(5):666-73. PubMed ID: 24219333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ANTITHROMBIN ACTIVITY (HEPARIN CO-FACTOR) IN PLASMA AFTER MAJOR SURGERY IN HEPARINIZED PATIENTS.
    OLSSON P; VON FRANCKEN ; NORDSTROEM S
    Acta Chir Scand; 1964 Jun; 127():578-83. PubMed ID: 14175132
    [No Abstract]   [Full Text] [Related]  

  • 16. [On serum and heparin antithrombin].
    JANUSZKO T
    Postepy Hig Med Dosw; 1961; 15():297-312. PubMed ID: 13789521
    [No Abstract]   [Full Text] [Related]  

  • 17. THE INFLUENCE OF INORGANIC SALTS ON PLASMA ANTITHROMBIN ACTIVITY.
    MONKHOUSE FC
    Thromb Diath Haemorrh; 1963 Jul; 143():387-94. PubMed ID: 14081261
    [No Abstract]   [Full Text] [Related]  

  • 18. [D-dimer, thrombin-antithrombin III-complex (TAT) and prothrombin fragment 1+2 (PTF). Parameters for monitoring therapy with low molecular-weight heparin in coagulation disorders].
    Hofmann M; Rest A; Hafner G; Tanner B; Brockerhoff P; Weilemann LS
    Anaesthesist; 1997 Aug; 46(8):689-96. PubMed ID: 9382207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulant effect of unfractionated heparin in antithrombin-depleted plasma in vitro.
    Krulder JW; Strebus AF; Meinders AE; Briët E
    Haemostasis; 1996; 26(2):85-9. PubMed ID: 9119287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Principles of the treatment of hypercoagulabilities with a rational anticoagulant therapy].
    Raby C
    Presse Med (1893); 1969 Jan; 77(1):17-9. PubMed ID: 5785756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.